Literature DB >> 10992893

[Attention deficit hyperactivity disorder (ADHD): etiology, diagnosis and treatment].

J K Buitelaar1, J J Kooij.   

Abstract

ADHD is a highly hereditary and persistent disorder with structural and functional abnormalities of the fronto-striatal circuits at group level as revealed by neuroimaging studies. There is no psychological or biological diagnostic test available. The diagnosis 'ADHD' is made on the basis of a careful and systematic review of the clinical characteristics as obtained from reports by parents, teachers and the child itself, and of own observation. Effective treatments include the prescription of medication (particularly psychostimulants) and behaviour therapy. Medication is more effective than behaviour therapy in affecting the core symptoms of ADHD and is therefore the first choice of treatment, except in children under 5 years of age. Treatment should be monitored at regular times. In case of insufficient response to monotherapy, combination treatment should be offered. Early recognition and appropriate assessment and treatment of ADHD requires collaboration between general practitioner, primary care psychologist, educational system, school doctors and nurses, child guidance system, paediatricians and child mental health system and child psychiatry, and adult psychiatry.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992893

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  3 in total

1.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

2.  Neuroimaging of response interference in twins concordant or discordant for inattention and hyperactivity symptoms.

Authors:  D van 't Ent; C E M van Beijsterveldt; E M Derks; J J Hudziak; D J Veltman; R D Todd; D I Boomsma; E J C De Geus
Journal:  Neuroscience       Date:  2009-02-03       Impact factor: 3.590

3.  Objective versus subjective assessment of methylphenidate response.

Authors:  Iris Manor; Sheera Meidad; Gil Zalsman; Zvi Zemishlany; Sam Tyano; Abraham Weizman
Journal:  Child Psychiatry Hum Dev       Date:  2007-12-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.